4
Changes in Ownership
NextCure, Inc. Filed Acc 0000905148-24-001051
Options or other derivatives
- Chief Scientific Officer acquired 93,900 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Langermann Sol Chief Scientific Officer | 2024-03-29 | Grant or award · Employee Stock Option (Right to Buy) | +93,900 | 93,900 | D | ||
Loading xslF345X05/form4.xml…